Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease

The effect of Alzheimer’s disease (AD) medications on CD4+ T cells homing has not been thoroughly investigated. CD4+ T cells could both exacerbate and reduce AD symptoms based on their infiltrating subpopulations. Proinflammatory subpopulations such as Th1 and Th17 constitute a major source of proin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubick, Norwin, Flournoy, Patrick C. Henckell, Enciu, Ana-Maria, Manda, Gina, Mickael, Michel-Edwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558445/
https://www.ncbi.nlm.nih.gov/pubmed/32948022
http://dx.doi.org/10.3390/pharmaceutics12090880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558445/
https://www.ncbi.nlm.nih.gov/pubmed/32948022
http://dx.doi.org/10.3390/pharmaceutics12090880

Ejemplares similares